These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 137092)

  • 21. Dietary fat and immune function. I. Antibody responses, lymphocyte and accessory cell function in (NZB x NZW)F1 mice.
    Morrow WJ; Ohashi Y; Hall J; Pribnow J; Hirose S; Shirai T; Levy JA
    J Immunol; 1985 Dec; 135(6):3857-63. PubMed ID: 2415589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain.
    Friedmann D; Yachimovich N; Mostoslavsky G; Pewzner-Jung Y; Ben-Yehuda A; Rajewsky K; Eilat D
    J Immunol; 1999 Apr; 162(8):4406-16. PubMed ID: 10201976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with antibody reactive with the nephritogenic idiotype, IdLNF1, suppresses its production and leads to prolonged survival of (NZB x SWR)F1 mice.
    Uner AH; Knupp CJ; Tatum AH; Gavalchin J
    J Autoimmun; 1994 Feb; 7(1):27-44. PubMed ID: 8198700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice.
    Adam C; Thoua Y; Ronco P; Verroust P; Tovey M; Morel-Maroger L
    Clin Exp Immunol; 1980 May; 40(2):373-82. PubMed ID: 6160000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.
    Carlsten H; Holmdahl R; Tarkowski A
    Immunology; 1991 Jun; 73(2):186-90. PubMed ID: 2071164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virus-induced immune complex disease: genetic control of C1q binding complexes in the circulation of mice persistently infected with lymphocytic choriomeningitis virus.
    Oldstone MB; Tishon A; Buchmeier MJ
    J Immunol; 1983 Feb; 130(2):912-8. PubMed ID: 6217255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanism of action of cyclophosphamide on the nephritis of (NZB x NZW)F1 hybrid mice.
    Hurd ER; Ziff M
    Clin Exp Immunol; 1977 Jul; 29(1):132-9. PubMed ID: 302170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theophylline prolongs survival and decreases renal damage in female NZB/W F-1 mice.
    Gelber M; Sidi Y; Ben-Bassat M; Shohat B; Pinkhas J; Weinberger A
    Thymus; 1988; 11(4):231-41. PubMed ID: 2972091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetic contribution of the NZB mouse to the renal disease of the NZB x NZW hybrid.
    Knight JG; Adams DD; Purves HD
    Clin Exp Immunol; 1977 May; 28(2):352-8. PubMed ID: 872452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phagocytic cells in glomerular cultures from NZB/W mice.
    McGiven AR; Hunt JS; Day WA; Jackson AE
    Br J Exp Pathol; 1981 Feb; 62(1):59-64. PubMed ID: 7225291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demonstration of activation of B lymphocytes in New Zealand black mice at birth by an immunoradiometric assay for murine IgM.
    Moutsopoulos HM; Boehm-Truitt M; Kassan SS; Chused TM
    J Immunol; 1977 Nov; 119(5):1639-44. PubMed ID: 303246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease.
    Fournie GJ; Minh MG; Mignon-Conte MA; Hass S; Lambert PH; Conte JJ
    J Clin Lab Immunol; 1980 Sep; 4(2):103-6. PubMed ID: 7441709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormalities of third-order suppressor T cells in old (New Zealand black x New Zealand white) F1 mice.
    Okuda K; Nagaoka S; Katoh K; Matsunaga K; Ishigatubo Y; Minami M; Tani K
    Immunology; 1984 Nov; 53(3):553-61. PubMed ID: 6208147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The uptake and degradation of DNA is impaired in macrophages and dendritic cells from NZB/W F(1) mice.
    Ogawa Y; Yoshinaga T; Yasuda K; Nishikawa M; Takakura Y
    Immunol Lett; 2005 Oct; 101(1):32-40. PubMed ID: 15979158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice. II. Prevention of glomerulonephritis.
    Zurier RB; Damjanov I; Sayadoff DM; Rothfield NF
    Arthritis Rheum; 1977; 20(8):1449-56. PubMed ID: 144506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.
    Wang Y; Hu Q; Madri JA; Rollins SA; Chodera A; Matis LA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8563-8. PubMed ID: 8710910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophages in NZB/NZW mouse glomerular disease.
    Hunt JS; McGiven AR; Jackson AE; Day WA
    Ren Physiol; 1980; 3(1-6):368-74. PubMed ID: 6459625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoregulation in New Zealand mice. I. Failure of the transfer of syngeneic spleen or thymus cells to influence the natural disease in New Zealand mice.
    Hoffman AA; Harbeck RJ
    Arthritis Rheum; 1979 Apr; 22(4):412-8. PubMed ID: 154894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice.
    Yoshiki T; Mellors RC; Strand M; August JT
    J Exp Med; 1974 Oct; 140(4):1011-27. PubMed ID: 4279268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of antibody affinity to onset of immune complex disease in New Zealand mice.
    Petty RE; Steward MW
    Ann Rheum Dis; 1977 Feb; 36(1):39-43. PubMed ID: 139132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.